Ste-Julie, Canada

Yves Dumoulin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 87(Granted Patents)


Location History:

  • Boucherville, CA (1995)
  • Ste-Julie, CA (1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yves Dumoulin: Innovator in Pharmaceutical Technology

Introduction

Yves Dumoulin is a notable inventor based in Ste-Julie, Canada. He has made significant contributions to the field of pharmaceutical technology, holding three patents that focus on innovative drug delivery systems. His work emphasizes the importance of enhancing the efficacy and efficiency of solid dosage forms.

Latest Patents

One of Yves Dumoulin's latest patents is titled "Cross-linked amylose as a binder/disintegrant in tablets." This invention addresses the manufacture of solid dosage units, particularly in pharmaceuticals. It involves the use of cross-linked amylose powders with a specific cross-linking degree, which serve as effective tablet binders and disintegrants.

Another significant patent is "Cross-linked enzymatically controlled drug release." This application focuses on a solid slow-release pharmaceutical dosage unit. The invention describes a tablet form created through direct compression of cross-linked amylose, which allows for sustained drug release. The inclusion of .alpha.-amylase in the tablet modulates the release time of the drug, making it dependent on the amount of enzyme present.

Career Highlights

Yves Dumoulin is currently associated with Labopharm Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new formulations that improve drug delivery and patient outcomes.

Collaborations

Throughout his career, Yves has collaborated with several professionals in the field, including Mircea Alexandru Mateescu and Vincent Lenaerts. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yves Dumoulin's contributions to pharmaceutical technology through his innovative patents highlight his role as a key inventor in the industry. His work continues to influence the development of effective drug delivery systems, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…